Description:

SOUTHWEST ONCOLOGY GROUP S0221 PACLITAXEL ADVERSE EVENT FORM Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BACD4035-5205-6831-E034-0003BA12F5E7

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BACD4035-5205-6831-E034-0003BA12F5E7

Keywords:
Versions (4) ▾
  1. 8/26/12
  2. 1/9/15
  3. 1/9/15
  4. 1/9/15
Uploaded on:

January 9, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Breast Cancer NCT00070564 Toxicity - SOUTHWEST ONCOLOGY GROUP S0221 PACLITAXEL ADVERSE EVENT FORM - 2101286v3.0

No Instruction available.

  1. StudyEvent: SOUTHWEST ONCOLOGY GROUP S0221 PACLITAXEL ADVERSE EVENT FORM
    1. No Instruction available.
Header
Adverse Events
Common Toxicity Criteria Adverse Event Term Type
CTC Adverse Event Attribution Scale
Comments
Ccrr Module For Southwest Oncology Group S0221 Paclitaxel Adverse Event Form

Similar models